Moreover, CLEC4A expression is associated with longer overall survival of patients with stage I, III, and IV colon cancer (HR < 1), although it is only significant in stage III (Supplementary Fig. S1B). This evidence concerns the gene CLEC4A and malignant colon neoplasm.